Medicinal product "Kordaron". Instructions

The drug "Cordarone" is an antiarrhythmic drug. The medication is used to provide antiarrhythmic and antianginal action.

The medicinal product "Cordarone", the instruction to which describes the release form of the drug, is produced by the pharmacological industry in the form of tablets and a solution. The appointment of a medicine is carried out by a specialist. The drug, sold in the form of tablets, is white. Cream tint is possible. One side of the tablet is an engraved symbol that includes a heart image and a 200 digit. The dosage form has a fault line for easy division into two equal parts. The solution intended for injection is a clear liquid without sediment. The main active substance of the drug is amiodarone hydrochloride. The auxiliary elements of the medicament are: lactose monohydrate, corn starch, colloidal anhydrous silicon dioxide, magnesium stearate and polyvidon K90F.

The drug "Kordaron", the instruction to which explains the main area of application of the drug, is prescribed by a specialist for cupping:

- attacks of ventricular tachycardia of a paroxysmal nature;

- atrial fibrillation, which has a stable and paroxysmal form;

- Atrial flutter ;

- attacks of supraventricular tachycardia paroxysmal form.

It is recommended to use the medication when taking preventive measures aimed at preventing relapses of the following situations:

- ventricular arrhythmias in case of life threatening;

- Atrial fibrillation ;

Paroxysmal supraventricular tachycardia ;

- Atrial flutter;

- threatening the life of heart ventricular fibrillation .

The attending physician may recommend the use of the drug to patients who have recently suffered a myocardial infarction and have manifestations of cardiac failure of a chronic nature, suffer from a decrease in the left ventricular ejection function. Admission of the drug to such patients can reduce the risk of sudden arrhythmic death. Finds the drug "Cordarone" application in the course of treatment of patients suffering from heart muscle diseases of an organic nature, which are accompanied by dysfunctions of the left heart ventricle. The use of a solution for injections is possible only under stationary conditions under the supervision of a specialist, when it is necessary to achieve antiarrhythmic action in a short time, or when the patient is simply unable to take Cordarone tablets.

The drug has an antianginal and antiarrhythmic effect on the cardiac muscle. Pharmacology of the drug "Cordarone" (the instruction to which describes its mechanism of influence on the body), is the effect of the main component component. Amiodarone hydrochloride reduces the volume of potassium through the channels of cell membranes, and the automatism of the sinus node. Due to blockade of adrenoreceptors, the nodal and sinoatrial atrial conductivity is deactivated. Thus, the drug produces an antiarrhythmic effect, increasing the third phase of the action potential of the myocardium. The drug reduces the excitability of the heart muscle, raises the refractory period and slows down the excitatory process in the ventricular ways. Antianginal action of the drug is carried out through an influence aimed at reducing the amount of oxygen consumed by the myocardium.

Medication "Cordarone", the instruction to which warns about undesirable side effects that arise when using a medication, can cause bradycardia, a feeling of heat, conduction disorders, sinus blockade, increased separation of sweat, liver failure, etc.